Trials / Completed
CompletedNCT03236740
OCP vs Metformin on Ovarian Stromal Blood Flow in PCOS
Doppler Analysis of Ovarian Stromal Blood Flow Changes After Treatment With Metformin Versus Ethinylestradiol-cyproterone Acetate in Women With Polycystic Ovarian Syndrome
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- S.C.B. Medical College and Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
This study is undertaken to compare the effects of treatment with commonly used OCP containing ethinylestradiol-cyproterone acetate and metformin in women with PCOS. Special attention will be paid to changes in ovarian stromal blood flow by using Color Doppler and they will be correlated with changes in hormonal parameters post-treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ethinyl Estradiol-cyprosterone acetate | Ethinyl Estradiol-cyprosterone acetate in the form of OCPs will be taken cyclically by the participants. |
| DRUG | Metformin Hydrochloride | Metformin Hydrochoride in the form of 500 mg tablets will be taken twice daily by participants. |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2018-03-01
- Completion
- 2018-03-15
- First posted
- 2017-08-02
- Last updated
- 2018-03-20
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT03236740. Inclusion in this directory is not an endorsement.